Literature DB >> 21536362

Guidelines for the selection of lung transplantation candidates.

Antonio Román1, Pietat Ussetti, Amparo Solé, Felipe Zurbano, José M Borro, José M Vaquero, Alicia de Pablo, Pilar Morales, Marina Blanco, Carlos Bravo, José Cifrian, Mercedes de la Torre, Pablo Gámez, Rosalía Laporta, Víctor Monforte, Roberto Mons, Angel Salvatierra, Francisco Santos, Joan Solé, Andrés Varela.   

Abstract

The present guidelines have been prepared with the consensus of at least one representative of each of the hospitals with lung transplantation programs in Spain. In addition, prior to their publication, these guidelines have been reviewed by a group of prominent reviewers who are recognized for their professional experience in the field of lung transplantation. Within the following pages, the reader will find the selection criteria for lung transplantation candidates, when and how to remit a patient to a transplantation center and, lastly, when to add the patient to the waiting list. A level of evidence has been identified for the most relevant questions. Our intention is for this document to be a practical guide for pulmonologists who do not directly participate in lung transplantations but who should consider this treatment for their patients. Finally, these guidelines also propose an information form in order to compile in an organized manner the patient data of the potential candidate for lung transplantation, which are relevant in order to be able to make the best decisions possible.
Copyright © 2011 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21536362     DOI: 10.1016/j.arbres.2011.03.007

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  5 in total

1.  Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.

Authors:  Maher Y Abdalla; Barbara L Switzer; Christopher H Goss; Moira L Aitken; Pradeep K Singh; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

2.  Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data.

Authors:  Alejandro Robles-Perez; Jordi Dorca; Ivan Castellví; Joan Miquel Nolla; Maria Molina-Molina; Javier Narváez
Journal:  Rheumatol Int       Date:  2020-03-10       Impact factor: 2.631

3.  Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells.

Authors:  Maher Y Abdalla; Iman M Ahmad; Barbara Switzer; Bradley E Britigan
Journal:  Redox Biol       Date:  2015-01-20       Impact factor: 11.799

4.  Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain--results of a Delphi Panel.

Authors:  Ferran Morell; Dirk Esser; Jonathan Lim; Susanne Stowasser; Alba Villacampa; Diana Nieves; Max Brosa
Journal:  BMC Pulm Med       Date:  2016-01-12       Impact factor: 3.317

Review 5.  Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes.

Authors:  Jaume Sauleda; Belén Núñez; Ernest Sala; Joan B Soriano
Journal:  Med Sci (Basel)       Date:  2018-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.